91AV

Introduction

With over 300 attendees expected, this multi-track event builds on the success of our Cambridge Workshop Series and will feature four tracks:

• Epigenetics in Drug Discovery
• Antibodies in Drug Discovery
• Academic Drug Discovery
• Stem Cells in Drug Discovery

As a multi-track event, delegates will have unrestricted access to all conference tracks and networking opportunities. If you are looking to hear from the experts; learn new skills; discover new ideas, trends & concepts; Advances in Drug Discovery 2017 is not to be missed.

Keynote Speakers:

Rakesh Dixit
Vice President/Global Head, MedImmune Inc

Michelle Arkin
Director of the Small Molecule Discovery Center, University of California San Francisco

Ludovic Vallier
Professor, University Of Cambridge

Stefan Knapp
Professor, Goethe Institut Franfurt

James Audia
Chief Scientific Officer, Constellation Pharmaceuticals

Sir Alan Fersht
Professor, MRC Laboratory of Molecular Biology

Christine Mummery
Professor and Chair of Developmental Biology, Leiden University Medical Centre

Sally Ward
Professor, Texas A&M Health Science Center

Danica Fujimori
Principal Investigator, University of California, San Francisco

Paul Workman
Chief Executive and President, Institute of Cancer Research, London

Dafydd Owen
Associate Research Fellow, Pfizer Ltd
 

Deadlines

• Feb 03 2017
  Early bird registration deadline

  
• Feb 20 2017
  Poster abstract deadline

  
• Mar 03 2017
  Standard registration deadline

  

Useful links

Venue

Wellcome Genome Campus Conference Centre

Wellcome Genome Campus Conference Centre, Hinxton, Cambridge, CB10 1RQ, United Kingdom

Organised by

SELECTBIO
Woodview
Bull Lane Industrial Est 
Acton
Sudbury 
Suffolk
CO10 0FD

Contact information

Philippa Matthews
SELECTBIO
+44 (0) 1787 275642
Contact us by email

---